BioFrontera bows bold imagery websites amid Q1 sales gains in dermatology
Sharks lurking under the skin and grimacing impetigo lesions are the striking images topping BioFrontera’s new and revamped websites for its flagship brands Ameluz and Xepi, respectively.
The skin specialist biopharma’s Ameluz site is its first aimed at patients while the Xepi revamp expands information and resources for both patients and physicians in the now one-stop site.
Ameluz is a gel used in photodynamic therapy along with a specialized lamp to treat actinic keratosis (AK) lesions on the face and scalp. AK, also called solar keratosis, is a type of pre-cancer that if untreated can develop into squamous cell carcinoma. The shark-shaped protrusions appear on the scalp of a man who also has lesions on the new Ameluz page under the headline “When danger lurks below the surface.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
